Alcohol detox for Fort Lauderdale — CIWA-Ar-guided, medically supervised, discretion assured.

For Fort Lauderdale residents in Las Olas, Victoria Park, or Coral Ridge, RECO Island's Delray Beach campus sits 40 minutes north on I-95 — a small-census, physician-led detox with CIWA-Ar-scored benzodiazepine tapers, parenteral thiamine on day one, and 24/7 nursing under physician oversight. The break from Fort Lauderdale nightlife and drinking triggers is deliberate, not incidental. When detox stabilizes, patients transition directly in-house to residential treatment — no waitlist, no third-party handoff, same clinical team through PHP and IOP step-down.

From Las Olas or Victoria Park, RECO Island’s Delray Beach campus sits roughly 40 minutes north on I-95 — close enough that family can attend weekend sessions without hotels, far enough that the break from Fort Lauderdale bars, drinking friends, and familiar triggers is geographic rather than merely intended. For Fort Lauderdale residents entering alcohol detox, that 26-mile buffer is deliberate: physician-led, nurse-staffed medical withdrawal management in a small-census setting, with direct in-house transition to residential treatment when detox stabilizes — no waitlist, no third-party handoff.

Alcohol withdrawal is the substance withdrawal that can kill you

Alcohol occupies a unique position among substances of abuse: its withdrawal syndrome carries genuine mortality. Opioid withdrawal is miserable but rarely fatal in medically stable adults; stimulant withdrawal is dysphoric but not physiologically dangerous. Alcohol withdrawal, by contrast, produces generalized tonic-clonic seizures in roughly 3-5% of untreated cases and delirium tremens in approximately 5%, with historical mortality for untreated DTs reported between 5% and 15%. Cardiovascular complications driven by autonomic hyperactivity add further risk in older adults or those with underlying coronary disease.

Risk stratification at intake is the foundation of a safe detox. The strongest single predictor of complicated withdrawal is a documented history of prior withdrawal seizures or DTs — kindling makes each subsequent withdrawal worse. Other risk factors include high daily alcohol volume (particularly above a fifth of liquor daily or its equivalent), duration of heavy use measured in years, age over 65, hepatic dysfunction, heart failure, and concurrent benzodiazepine or GHB dependence. RECO Island’s admission physicians assess each of these factors and adjust monitoring frequency, medication protocol, and staffing intensity accordingly.

This is why medical detox — not an outpatient taper, not a home attempt with a friend-of-a-friend Librium script — is the standard of care for alcohol use disorder. The ASAM Criteria place moderate-to-severe alcohol withdrawal at Level 3.7 or higher, medically monitored inpatient withdrawal management, and RECO Island’s detox unit is staffed to that standard.

CIWA-Ar scoring and symptom-triggered benzodiazepine dosing

The Clinical Institute Withdrawal Assessment for Alcohol, revised (CIWA-Ar), is the assessment scale used at RECO Island and at virtually every credible medical detox in the United States. It scores ten symptom domains — nausea and vomiting, tremor, paroxysmal sweats, anxiety, agitation, orientation and clouding of sensorium, tactile disturbances, auditory disturbances, visual disturbances, and headache — each on a defined ordinal scale. Total scores stratify severity: below 10 mild, 10-18 moderate, above 18 severe.

Nursing staff reassess CIWA-Ar at intervals matched to severity — typically every hour during active symptomatic withdrawal and every four hours once scores stabilize below threshold. Benzodiazepines are administered when scores cross a defined treatment threshold, commonly 8 or 10. The specific agent depends on the clinical picture: chlordiazepoxide for uncomplicated withdrawal with intact hepatic function, lorazepam for patients with hepatic impairment or older adults where metabolism matters, diazepam for rapid loading in severe presentations.

Symptom-triggered dosing outperforms fixed-schedule dosing on every measured endpoint — total benzodiazepine dose, length of stay, and rate of complicated withdrawal — and is the protocol recommended by the American Society of Addiction Medicine. Fixed schedules over-medicate mild withdrawal and under-medicate severe withdrawal; symptom-triggered dosing individualizes the taper to what the patient’s autonomic nervous system is actually doing hour by hour.

Thiamine, folate, and Wernicke’s prevention

Chronic alcohol use produces thiamine (vitamin B1) deficiency through poor dietary intake, impaired absorption, and altered hepatic storage. Untreated deficiency produces Wernicke’s encephalopathy — the triad of ocular abnormalities, ataxia, and confusion — which, if uncorrected, progresses to Korsakoff’s syndrome, a permanent anterograde amnestic disorder. The neurologic damage does not reverse.

RECO Island’s admission protocol includes parenteral thiamine (100 mg IM or IV) on day one for every patient with an alcohol use disorder diagnosis, regardless of presentation. Folate 1 mg daily, a B-complex multivitamin, and magnesium replacement — magnesium depletion lowers seizure threshold and worsens tremor — complete the standard regimen. Patients with signs suggestive of Wernicke’s (nystagmus, gait ataxia, confusion out of proportion to withdrawal) receive higher-dose thiamine (500 mg IV three times daily) per current neurology guidance. This is not optional; any detox that skips it is failing basic standard of care.

MAT initiation during detox and the bridge to residential

Medical detox alone is not treatment for alcohol use disorder — it is preparation for treatment. Untreated AUD has 12-month relapse rates that make detox-alone protocols effectively a revolving door. RECO Island’s clinical model addresses this by initiating medication-assisted treatment during the detox stay, so pharmacotherapy is already established when the patient transitions to residential.

Three FDA-approved medications carry solid evidence for AUD. Naltrexone (oral 50 mg daily or long-acting injectable Vivitrol 380 mg IM monthly) reduces heavy drinking and craving by blocking the mu-opioid receptor; it requires a 7-10 day opioid-free window, which detox provides. Acamprosate (666 mg three times daily) normalizes glutamatergic tone and is initiated once abstinence is stabilized, typically day 5-7. Disulfiram (250 mg daily) remains an option for motivated patients with structured accountability.

The MAT decision is made collaboratively with physician, patient, and — with written consent — family. Comorbid depression, anxiety, or PTSD, which the intake psychiatric evaluation screens for using the PHQ-9, GAD-7, and PCL-5, often warrants concurrent initiation of an SSRI (sertraline, escitalopram) or a non-addictive anxiolytic (buspirone, hydroxyzine) during the residential phase. Trauma-focused work — CBT, EMDR, or prolonged exposure — is sequenced after physiologic stabilization, not during acute withdrawal.

What to expect on your first day at RECO Island

Arrival at the Delray Beach campus begins with medical intake: vital signs, breathalyzer or blood alcohol level, comprehensive metabolic panel, complete blood count, magnesium and phosphorus, liver function tests, urine drug screen, and EKG for patients over 40 or with cardiac risk factors. A physician performs history and physical; nursing establishes the baseline CIWA-Ar. Parenteral thiamine and folate are administered on day one.

A concurrent psychiatric and substance-use assessment maps the ASAM Criteria’s six dimensions — acute intoxication and withdrawal potential, biomedical conditions, emotional and cognitive conditions, readiness to change, relapse potential, and recovery environment. That dimensional assessment drives the initial treatment plan and level-of-care recommendations at each subsequent step-down. Withdrawal medication is initiated based on presenting CIWA-Ar and risk stratification, and the patient is oriented to a small-census unit with 24/7 nursing and physician on-call.

Admissions and insurance from Fort Lauderdale

RECO Island is in-network with most major commercial carriers used by Fort Lauderdale employers and individuals — Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and Blue Cross Blue Shield out-of-state plans. Admissions runs a verification of benefits typically within an hour, quoting deductible status, out-of-pocket maximum, and any prior-authorization requirements for medically monitored inpatient withdrawal management.

Admissions from Fort Lauderdale generally move same-day when medically appropriate. Family can arrange drop-off from Las Olas, Victoria Park, Coral Ridge, Rio Vista, or Wilton Manors, and airport pickup from Fort Lauderdale-Hollywood International (FLL) can be coordinated for out-of-state family bringing a loved one north to Delray Beach.

Serving residents of: Las Olas, Victoria Park, Coral Ridge, Rio Vista, Wilton Manors.